Industry

Genetic Testing Market Research 2025: Analysis with Forecasts by Applications, Technologies, Products and Users with Executive and Consultant Guides – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Genetic Testing Markets. Global Market Analysis with Forecasts by Applications, Technologies, Products and Users with Executive and Consultant Guides” has been added to ResearchAndMarkets.com’s offering. The genetic testing industry is experiencing unprecedented growth, with its potential proving boundless as it expands across various sectors. This growth is being propelled by advancements in our … [Read more…]

KalVista Pharmaceuticals Presents New Data at the European Academy of Allergy and Clinical Immunology Congress 2025 on the Efficacy of Sebetralstat for the On-demand Treatment of HAE Attacks Among Patients Receiving Long-Term Prophylaxis

–Real-world data highlight significant challenges with LTP adherence, and ongoing reliance on on-demand medications– –In KONFIDENT-S, oral sebetralstat delivered rapid, consistent relief for breakthrough attacks, regardless of long-term prophylaxis mechanism of action– CAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)–KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the presentation of new data at the European Academy of Allergy … [Read more…]

Genentech to Advance Prasinezumab Into Phase III Development for Early-Stage Parkinson’s Disease

– Results from Phase IIb PADOVA and longer term follow-up data suggest clinical benefit on top of symptomatic treatment in early-stage Parkinson’s disease – – Prasinezumab is a potential first-in-class anti-alpha-synuclein antibody, targeting a known biological driver of Parkinson’s disease progression – – Parkinson’s disease affects over 10 million people globally and significant unmet need … [Read more…]

HekaBio, Japan-based Biopharma and MedTech Platform, Enters Strategic Partnership with Alfresa Holdings Corporation

~~Accelerating Access to Innovative Therapies in Japan through Alfresa Group’s ‘Total Supply Chain Service’~~ TOKYO–(BUSINESS WIRE)–HekaBio K.K. (Headquarters: Chuo-ku, Tokyo; President & CEO: Robert E. Claar; hereinafter “HekaBio”) today announced the signing of a strategic partnership agreement with Alfresa Holdings Corporation (Headquarters: Chiyoda-ku, Tokyo; Representative Director & President: Ryuji Arakawa; hereinafter “Alfresa Holdings”), the leading … [Read more…]

Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)

Results from the EPCORE® NHL-2 trial show investigational treatment with epcoritamab in combination with rituximab, ifosfamide, carboplatin, and etoposide (R-ICE) led to an overall response rate (ORR) of 87 percent and a complete response (CR) rate of 65 percent in patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) Data further demonstrates the … [Read more…]

QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs)

QIAGEN to create a multimodal panel using next-generation sequencing (NGS) technology for detecting clinically relevant gene alterations in hematological malignancies Companion diagnostic to identify key disease-causing mutations in patients with MPNs, with an initial focus on mutant CALR the second most common driver of MPNs Panel to be validated on Illumina NextSeq 550Dx platform for … [Read more…]

WSIB Workers Face More Than Double the National Rates of Anxiety and Depression, Survey Finds

TORONTO–(BUSINESS WIRE)–#CUPE–The union representing striking workers at the Workplace Safety and Insurance Board (WSIB) has conducted a follow-up survey to assess workload and occupational stress levels, one year after their initial study. The internationally recognized survey, conducted by the Occupational Health Clinics for Ontario Workers (OHCOW), an independent third party, shows that WSIB workers continue … [Read more…]

VIQ Solutions Announces Voting Results From Annual Meeting of Shareholders

MISSISSAUGA, Ontario–(BUSINESS WIRE)–VIQ Solutions Inc. (“VIQ”, “VIQ Solutions” or the “Company”) (TSX: VQS), a global provider of secure, AI-driven, digital voice and video capture technology and transcription services, announced the voting results from its annual general meeting of shareholders (the “Meeting”) on June 13, 2025. Shareholders approved all matters set forth in the Company’s management … [Read more…]

Breast Cancer Canada Applauds Federal Commitment to Modernize Preventive Health Guidelines

Inclusion of experts, patient voices, and equity-focused policy reflects priorities long championed by Breast Cancer Canada TORONTO–(BUSINESS WIRE)–Breast Cancer Canada proudly celebrates the federal government’s response to the External Expert Review (EER) of the Canadian Task Force on Preventive Health Care, and the sweeping reforms it recommends to ensure preventive health guidance in Canada is … [Read more…]

Messenger RNA Market Global and Regional Analysis Report 2025-2035: Advancements in mRNA Technology, Rising Demand for mRNA Vaccines, and Growing Applications in Cancer Therapy Bolster Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Messenger RNA Market – A Global and Regional Analysis: Focus on Application and Regional Analysis – Analysis and Forecast, 2025-2035” report has been added to ResearchAndMarkets.com’s offering. The global messenger RNA market is currently in the growth stage of its lifecycle, driven by the rapid success of mRNA vaccines, particularly for COVID-19, which … [Read more…]